16 million NOK grant received from The Norwegian Research Council
16.5 million NOK raised in second financing round
Patent application covering multiple neo-antigens filed at the European Patent Office
If you wish to stay informed and follow the company’s progression you can subscribes to the newsletter here.
Download the media kit to get access to the company logos and a picture of our CEO.